Literature DB >> 8978784

The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies.

I Wlodarska1, P Marynen, R La Starza, C Mecucci, H Van den Berghe.   

Abstract

Structural rearrangements including deletions of the short arm of chromosome 12 are frequent cytogenetic findings in various hematologic malignant disorders. Using FISH with a panel of DNA probes we detected loss of a common region of 12p in 22 patients with different hematologic disorders. Nine of them were characterized cytogenetically by a del(12p), seven by unbalanced translocations, and in the remaining cases the loss of the 12p region was masked by translocations and insertions, adding extra material to the short arm of chromosome 12. The smallest commonly deleted region found in all cases analyzed included ETV6, the gene for p27kipl (CDKN1B), and the D12S178 marker.

Entities:  

Mesh:

Year:  1996        PMID: 8978784     DOI: 10.1159/000134197

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  5 in total

1.  Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors.

Authors:  B Kazmierczak; P Dal Cin; S Wanschura; S Bartnitzke; H Van den Berghe; J Bullerdiek
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 2.  Multiple endocrine neoplasia syndromes associated with mutation of p27.

Authors:  M Lee; N S Pellegata
Journal:  J Endocrinol Invest       Date:  2013-06-26       Impact factor: 4.256

3.  Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter.

Authors:  S Fears; M Gavin; D E Zhang; C Hetherington; Y Ben-David; J D Rowley; G Nucifora
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

4.  TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.

Authors:  R Fenrick; L Wang; J Nip; J M Amann; R J Rooney; J Walker-Daniels; H C Crawford; D L Hulboy; M S Kinch; L M Matrisian; S W Hiebert
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity.

Authors:  Sarah B Mueller; Paola Dal Cin; Long P Le; Dora Dias-Santagata; Jochen K Lennerz; A John Iafrate; Hetal Desai Marble; Andrew M Brunner; Matthew J Weinstock; Marlise R Luskin; Daniel J De Angelo; Richard M Stone; Valentina Nardi
Journal:  Blood Adv       Date:  2022-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.